Literature DB >> 21723246

Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy.

Joel Thompson1, Patricia Wilson, Katie Brandewie, Deepa Taneja, Liliana Schaefer, Bonnie Mitchell, Lisa R Tannock.   

Abstract

Hyperlipidemia worsens diabetic nephropathy, although the mechanism by which renal lipids accumulate is unknown. We previously demonstrated that renal proteoglycans have high low-density lipoprotein (LDL) binding affinity, suggesting that proteoglycan-mediated LDL retention may contribute to renal lipid accumulation. The aim of this study was to determine the relative effect of diabetes and hyperlipidemia on renal proteoglycan content. Diabetic and non-diabetic LDL receptor-deficient mice were fed diets containing 0% or 0.12% cholesterol for 26 weeks, and then kidneys were analyzed for renal lipid and proteoglycan content. Diabetic mice on the high-cholesterol diet had accelerated development of diabetic nephropathy with elevations in urine albumin excretion, glomerular and renal hypertrophy, and mesangial matrix expansion. Renal lipid accumulation was significantly increased by consumption of the 0.12% cholesterol diet, diabetes, and especially by both. The renal proteoglycans biglycan and decorin were detectable in glomeruli, with a significant increase in renal biglycan content in diabetic mice on the high-cholesterol diet. Renal biglycan and renal apolipoprotein B were colocalized, and regression analyses showed a significant relation between renal biglycan and renal apolipoprotein B content. The increased renal biglycan content in diabetic nephropathy probably contributes to renal lipid accumulation and the development of diabetic nephropathy.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21723246      PMCID: PMC3157166          DOI: 10.1016/j.ajpath.2011.05.016

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  65 in total

1.  Impact of genetic background on nephropathy in diabetic mice.

Authors:  Susan B Gurley; Sharon E Clare; Kamie P Snow; Ann Hu; Timothy W Meyer; Thomas M Coffman
Journal:  Am J Physiol Renal Physiol       Date:  2005-08-23

2.  Podocyte proteoglycan synthesis is involved in the development of nephrotic syndrome.

Authors:  A Björnson Granqvist; K Ebefors; M A Saleem; P W Mathieson; B Haraldsson; J Sörensson Nyström
Journal:  Am J Physiol Renal Physiol       Date:  2006-04-18

3.  Proteoglycans can mediate renal lipoprotein retention.

Authors:  L R Tannock
Journal:  Diabetologia       Date:  2006-03-11       Impact factor: 10.122

4.  Foam cells generated by a combination of hyperglycemia and hyperlipemia in rats.

Authors:  Jun-ichi Sano; Shiro Shirakura; Shoji Oda; Takuji Hara; Tokuhiro Ishihara
Journal:  Pathol Int       Date:  2004-12       Impact factor: 2.534

5.  Can murine diabetic nephropathy be separated from superimposed acute renal failure?

Authors:  Yuet-Ching Tay; Yiping Wang; Lukas Kairaitis; Gopala K Rangan; Chun Zhang; David C H Harris
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

6.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.

Authors:  A Hildebrand; M Romarís; L M Rasmussen; D Heinegård; D R Twardzik; W A Border; E Ruoslahti
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

7.  Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis.

Authors:  Wang Huijun; Chen Long; Zhang Zhigang; Jiang Feng; Guo Muyi
Journal:  Exp Mol Pathol       Date:  2005-02       Impact factor: 3.362

8.  Characterization of susceptibility of inbred mouse strains to diabetic nephropathy.

Authors:  Zhonghua Qi; Hiroki Fujita; Jianping Jin; Linda S Davis; Yihan Wang; Agnes B Fogo; Matthew D Breyer
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

9.  Primary human glomerular endothelial cells produce proteoglycans, and puromycin affects their posttranslational modification.

Authors:  Anna Björnson; Jonatan Moses; Annika Ingemansson; Börje Haraldsson; Jenny Sörensson
Journal:  Am J Physiol Renal Physiol       Date:  2004-12-07

10.  The effect of glucose on proteoglycans produced by cultured mesangial cells.

Authors:  S Silbiger; D Schlondorff; S Crowley; L Rosenberg; H Choi; V Hatcher; P Gordon
Journal:  Diabetes       Date:  1993-12       Impact factor: 9.461

View more
  22 in total

1.  Liver X receptors preserve renal glomerular integrity under normoglycaemia and in diabetes in mice.

Authors:  Monika Patel; Xiaoxin X Wang; Lilia Magomedova; Rohan John; Adil Rasheed; Hannah Santamaria; Weidong Wang; Ricky Tsai; Liru Qiu; Arturo Orellana; Andrew Advani; Moshe Levi; Carolyn L Cummins
Journal:  Diabetologia       Date:  2013-11-08       Impact factor: 10.122

2.  Elevated circulating TGF-β is not the cause of increased atherosclerosis development in biglycan deficient mice.

Authors:  Joel C Thompson; Patricia G Wilson; Alex P Wyllie; Adrian K Wyllie; Lisa R Tannock
Journal:  Atherosclerosis       Date:  2017-11-10       Impact factor: 5.162

Review 3.  Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis.

Authors:  Hans-Joachim Anders; Liliana Schaefer
Journal:  J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 10.121

Review 4.  Diabetic nephropathy and extracellular matrix.

Authors:  S O Kolset; F P Reinholt; T Jenssen
Journal:  J Histochem Cytochem       Date:  2012-10-27       Impact factor: 2.479

Review 5.  Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology.

Authors:  Madalina V Nastase; Renato V Iozzo; Liliana Schaefer
Journal:  Biochim Biophys Acta       Date:  2014-02-05

6.  Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition.

Authors:  Patricia G Wilson; Joel C Thompson; Meghan H Yoder; Richard Charnigo; Lisa R Tannock
Journal:  J Lipid Res       Date:  2017-09-14       Impact factor: 5.922

Review 7.  Small Leucine-Rich Proteoglycans in Renal Inflammation: Two Sides of the Coin.

Authors:  Madalina V Nastase; Andrea Janicova; Heiko Roedig; Louise Tzung-Harn Hsieh; Malgorzata Wygrecka; Liliana Schaefer
Journal:  J Histochem Cytochem       Date:  2018-01-01       Impact factor: 2.479

Review 8.  Soluble biglycan as a biomarker of inflammatory renal diseases.

Authors:  Louise Tzung-Harn Hsieh; Madalina-Viviana Nastase; Jinyang Zeng-Brouwers; Renato V Iozzo; Liliana Schaefer
Journal:  Int J Biochem Cell Biol       Date:  2014-08-01       Impact factor: 5.085

9.  Blocking ligand occupancy of the αVβ3 integrin inhibits the development of nephropathy in diabetic pigs.

Authors:  Laura A Maile; Walker H Busby; Katherine A Gollahon; William Flowers; Nikol Garbacik; Stefani Garbacik; Kara Stewart; Timothy Nichols; Dwight Bellinger; Amit Patel; Paul Dunbar; Matt Medlin; David Clemmons
Journal:  Endocrinology       Date:  2014-08-29       Impact factor: 4.736

10.  Decreased body fat, elevated plasma transforming growth factor-β levels, and impaired BMP4-like signaling in biglycan-deficient mice.

Authors:  Tao Tang; Joel C Thompson; Patricia G Wilson; Christina Nelson; Kevin Jon Williams; Lisa R Tannock
Journal:  Connect Tissue Res       Date:  2012-08-23       Impact factor: 3.417

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.